Anti-inflammatory cream reduces skin damage induced by ionizing radiation

Oncologist

Volumn 14, Issue 2, 2009, Pages 197-198

  Simard, Philippe F ^a,b   Bolto, Rachel M ^a   Tarbell, Nancy J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; TRIETHANOLAMINE SALICYLATE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHONDROSARCOMA; CREAM; ERYTHEMA; HUMAN; IONIZING RADIATION; LETTER; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION PROTECTION; SKIN EDEMA; TOPICAL TREATMENT;

ANTI-INFLAMMATORY AGENTS; BONE NEOPLASMS; CHONDROSARCOMA; EMOLLIENTS; HUMANS; RADIODERMATITIS; RADIOTHERAPY;

EID: 63849187638     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0256     Document Type: Letter

References (4)

1. Blanco AI, Chao C. Management of radiation-induced head and neck injury. Cancer Treat Res 2006;128:23-41.
2. Sitton E. Early and late radiation-induced skin alterations. Part I: Mechanisms of skin changes. Oncol Nurs Forum 1992;19:801-807.
3. Hei TK. Cyclooxygenase-2 as a signaling molecule in radiation-induced bystander effect. Mol Carcinog 2006;45:455-460.
4. Liang L, Hu D, Liu W et al. Celecoxib reduces skin damage after radiation: Selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 2003;26:S114-S121.